Expectant management versus immediate treatment for low‐grade cervical intraepithelial neoplasia
Authors:
Abstract
BACKGROUND: The optimal management strategy for women with low‐grade biopsy‐proven cervical intraepithelial neoplasia (CIN) is not clear. Our objective was to compare the effectiveness of regular colposcopic follow‐up and treatment of progressive disease only versus immediate treatment.METHODS: Data were accrued between November 2000 and March 2006 for a noninferiority randomized clinical trial of 415 women with biopsy‐proven grade 1 CIN from 8 Canadian and 2 Brazilian colposcopy clinics. Subjects were randomly assigned to either undergo immediate treatment with a loop electrical excision procedure (LEEP) or receive regular colposcopic follow‐up for 18 months. The primary outcome was progression of disease to CIN 2 to 3 was based on histology obtained during 18 months of follow‐up. Treatments were compared using differences of proportion with a 9% noninferiority margin. Analysis was conducted on the basis of intention‐to‐treat.RESULTS: An initial LEEP was performed on 179 women. Disease progression was found in 32. Easily controlled vaginal bleeding occurred in 16 (8.9%). During follow‐up, disease progression was identified in 3 (1.7%) women in the immediate treatment arm and 9 (4.4%) in the colposcopic follow‐up arm—a tolerable difference of 2.7% with 1‐sided 95% confidence interval (CI) upper limit of 6.0%. Compliance with all 3 follow‐up visits was 61% overall, but significantly worse in women ≤30 years of age (P < .05).CONCLUSIONS: The risk of progression to CIN grade 2 or 3 or cancer over 18 months was similar in the 2 treatment groups. In Canada and Brazil, follow‐up for 18 months is a reasonable management strategy for women with persistent low‐grade cytology who are found to have grade 1 CIN on referral for colposcopy and cervical biopsy. Cancer 2011. © 2010 American Cancer Society.Keywords
This publication has 17 references indexed in Scilit:
- Reproducibility of the Histological Diagnosis of Cervical Dysplasia Among Pathologists From 4 ContinentsInternational Journal of Gynecological Pathology, 2008
- 2006 Consensus Guidelines for the Management of Women With Cervical Intraepithelial Neoplasia or Adenocarcinoma In SituJournal of Lower Genital Tract Disease, 2007
- Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): Trial designContemporary Clinical Trials, 2006
- Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysisThe Lancet, 2005
- Management choice and adherence to follow-up after colposcopy in women with cervical intraepithelial neoplasia 12001
- Management of Colposcopy Patients with Biopsy-Proven Cervical Intraepithelial Neoplasia Grade 1Journal of Lower Genital Tract Disease, 1999
- Natural history of cervical squamous intraepithelial lesions: a meta-analysis*1Obstetrics & Gynecology, 1998
- High Long-Term Cure Rate Justifies Routine Treatment of Cervical Intraepithelial Neoplasia Grade IAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1995
- Natural History of Cervical Intraepithelial NeoplasiaInternational Journal of Gynecological Pathology, 1993
- Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non‐zero risk difference or non‐unity relative riskStatistics in Medicine, 1990